Allarity Therapeutics, Inc. (ALLR) Q4 2023 Annual Earnings
ALLR·Reported April 29, 2024·Before market open
Allarity Therapeutics, Inc. reported Q4 2023 revenue of $112.0K. Diluted EPS came in at $-175.51.
Revenue
$112.0K
Diluted EPS
$-175.51
Financial Snapshot
Trailing eight quarters through Q4 2023
Q4 2023 Earnings FAQ
Common questions about Allarity Therapeutics, Inc.'s Q4 2023 earnings report.
Allarity Therapeutics, Inc. (ALLR) reported Q4 2023 earnings on April 29, 2024 before market open.
Allarity Therapeutics, Inc. reported revenue of $112.0K and diluted EPS of $-175.51 for Q4 2023.
You can read the 10-K periodic report (0001213900-24-020864) directly on SEC EDGAR. The filing index links above go to sec.gov.